These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10203388)

  • 1. CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy.
    Meroni L; Varchetta S; Manganaro D; Moscatelli G; Moroni M; Galli M
    AIDS; 1999 Apr; 13(5):621-2. PubMed ID: 10203388
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J
    Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens.
    Smith KY; Steffens CM; Truckenbrod A; Landay A; Al-Harthi L
    J Acquir Immune Defic Syndr; 2002 Apr; 29(5):544-5. PubMed ID: 11981373
    [No Abstract]   [Full Text] [Related]  

  • 4. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).
    Gougeon ML; Lecoeur H; Sasaki Y
    Immunol Lett; 1999 Mar; 66(1-3):97-103. PubMed ID: 10203040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
    Fleury S; de Boer RJ; Rizzardi GP; Wolthers KC; Otto SA; Welbon CC; Graziosi C; Knabenhans C; Soudeyns H; Bart PA; Gallant S; Corpataux JM; Gillet M; Meylan P; Schnyder P; Meuwly JY; Spreen W; Glauser MP; Miedema F; Pantaleo G
    Nat Med; 1998 Jul; 4(7):794-801. PubMed ID: 9662370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.
    Barreiro PM; Dona MC; Castilla J; Soriano V
    AIDS; 1999 Mar; 13(4):525-6. PubMed ID: 10197384
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
    Lederman MM; McKinnis R; Kelleher D; Cutrell A; Mellors J; Neisler M; Cooney E; Haas DW; Haubrich R; Stanford J; Horton J; Landay A; Spreen W
    AIDS; 2000 Dec; 14(17):2635-42. PubMed ID: 11125881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiretroviral therapy in patients infected with HIV-1].
    Corti ME
    Medicina (B Aires); 1998; 58 Suppl 1():49-56. PubMed ID: 9674248
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T; Imami N; Nelson M; Gazzard BG; Bower M
    AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection.
    Giorgi JV; Majchrowicz MA; Johnson TD; Hultin P; Matud J; Detels R
    AIDS; 1998 Oct; 12(14):1833-44. PubMed ID: 9792384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir).
    Lori F; Jessen H; Lieberman J; Clerici M; Tinelli C; Lisziewicz J
    AIDS Res Hum Retroviruses; 1999 May; 15(7):619-24. PubMed ID: 10331440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir.
    Pelton SI; Johnson D; Chadwick E; Baldwin Z; Yogev R
    Pediatr Infect Dis J; 1999 Jul; 18(7):650-2. PubMed ID: 10440447
    [No Abstract]   [Full Text] [Related]  

  • 18. CD8 T-cell response to antiretroviral therapy.
    Stricker RB; Goldberg B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):176-7. PubMed ID: 9241121
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.
    Dybul M; Hidalgo B; Chun TW; Belson M; Migueles SA; Justement JS; Herpin B; Perry C; Hallahan CW; Davey RT; Metcalf JA; Connors M; Fauci AS
    J Infect Dis; 2002 Jan; 185(1):61-8. PubMed ID: 11756982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R; Kinloch S; Goh LE; Cooper D; Perrin L; Lampe F; Zaunders J; Hoen B; Tsoukas C; Andersson J; Janossy G;
    AIDS; 2002 Mar; 16(4):589-96. PubMed ID: 11873002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.